Suppr超能文献

一项将手臂静脉用作同侧大隐静脉不可用时腹股沟下旁路手术第一替代选择的政策的结果。

Results of a policy with arm veins used as the first alternative to an unavailable ipsilateral greater saphenous vein for infrainguinal bypass.

作者信息

Hölzenbein T J, Pomposelli F B, Miller A, Contreras M A, Gibbons G W, Campbell D R, Freeman D V, LoGerfo F W

机构信息

Harvard-Deaconess Surgical Service, New England Deaconess Hospital, Harvard Medical School, Boston, MA 02215, USA.

出版信息

J Vasc Surg. 1996 Jan;23(1):130-40. doi: 10.1016/s0741-5214(05)80043-6.

Abstract

PURPOSE

Aggressive policies for distal bypass and coronary revascularization increase the need to identify alternatives to autologous saphenous vein grafts. We examined the performance of arm vein as the primary alternative to contralateral saphenous vein when the ipsilateral saphenous vein was not available.

METHODS

A total of 250 arm vein grafts were studied retrospectively in 224 patients (143 men, 81 women, 82.6% with diabetes, mean age 68.3 years) from February 1989 to April 1994. Intraoperative angioscopy was carried out to observe valve lysis, remove abnormalities, and select optimal vein segments.

RESULTS

A total of 85 primary, 103 repeat, and 62 graft revision procedures were done for limb salvage in 99.2% of the patients. A total of 41 femoropopliteal, 114 femorotibial-pedal, 33 popliteodistal, and 62 jump or interposition grafts were constructed. A total of 199 grafts were single vein, and 51 were composite vein. The source was cephalic vein alone in 50.4%, cephalic and basilic vein in 35.6%, and basilic vein only in 14%. The contralateral saphenous vein as an alternative conduit was available in 97 (38.8%) instances. Interventions guided by angioscopy to "upgrade" the graft were necessary in 51.6%. Overall early patency (< or = 30 days) was 94.8% (n = 13 occlusions). The cumulative primary patency rate at 1 year was 70.6%, the secondary patency rate was 76.9%, and the limb salvage rate was 88.2%. The 3-year patency rate (limb salvage) was 51.9% (92.4%) for primary grafts, 56.7% (67.1%) in revision grafts, and 42.4% (79.9%) in repeat grafts. In 22.7% (22 of 97) the available contralateral saphenous vein was used for distal revascularization within the follow-up period.

CONCLUSIONS

Arm veins are an easily accessible autologous conduit of sufficient length to reach the midtibial level. Excellent patency rates allow durable limb salvage in otherwise difficult circumstances. Vein configuration and splicing do not affect patency rates, but vein quality and repeat operations do. Angioscopy is a valuable adjunct to upgrade graft quality. The contralateral saphenous should be saved for subsequent contralateral revascularization or coronary artery bypass grafting.

摘要

目的

积极的远端旁路移植和冠状动脉血运重建策略增加了寻找自体大隐静脉移植物替代物的需求。我们研究了在同侧大隐静脉不可用时,将手臂静脉作为对侧大隐静脉主要替代物的性能。

方法

回顾性研究了1989年2月至1994年4月期间224例患者(143例男性,81例女性,82.6%患有糖尿病,平均年龄68.3岁)的250条手臂静脉移植物。术中进行血管内镜检查以观察瓣膜溶解、清除异常并选择最佳静脉段。

结果

共进行了85例初次手术、103例再次手术和62例移植物修复手术,以挽救99.2%患者的肢体。共构建了41例股腘动脉、114例股胫-足部、33例腘动脉远端和62例跳跃或搭桥移植物。共有199条移植物为单条静脉,51条为复合静脉。来源仅为头静脉的占50.4%,头静脉和贵要静脉的占35.6%,仅为贵要静脉的占14%。在97例(38.8%)情况下可获得对侧大隐静脉作为替代管道。在51.6%的情况下需要血管内镜引导下的干预来“升级”移植物。总体早期通畅率(≤30天)为94.8%(13例闭塞)。1年时的累积原发性通畅率为70.6%,继发性通畅率为76.9%,肢体挽救率为88.2%。初次移植物的3年通畅率(肢体挽救)为51.9%(92.4%),修复移植物为56.7%(67.1%),再次移植物为42.4%(79.9%)。在随访期间,97例中有22.7%(22例)使用了可获得的对侧大隐静脉进行远端血运重建。

结论

手臂静脉是一种易于获取的自体管道,长度足以到达胫骨中部水平。出色的通畅率可在其他困难情况下实现持久的肢体挽救。静脉形态和拼接不影响通畅率,但静脉质量和再次手术会影响。血管内镜是提高移植物质量的有价值辅助手段。应保留对侧大隐静脉用于后续对侧血运重建或冠状动脉搭桥手术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验